HeyJaredAntoinette F. Konski
- Indexed articles, last 90 days
- 4
- Latest publication
- Aug 13, 2026
- Outlet visibility, for Mondaq
- Top 500K sites
- Earliest in this view
- Jul 13, 2026
Latest articles
Global AI Patent Surge: Trends, Dominance, And Strategy (opens the original)
Read excerpt
For patent attorneys, few technology areas demand closer attention right now than artificial intelligence (“GenAI”). Two reports from the World Intellectual Property Organization (“WIPO”) bracket a two-year window: the Patent Landscape Report: Generative Artificial Intelligence published in 2024 (the “2024 Report”) and the Patent Trends Update in GenAI published in 2026 (the “2026 Report”). Together, they offer a data-driven view of how AI patenting has evolved and what that evolution means for
Practical Guidance For Pharmaceutical Method-of-Use Patent Claims After Teva v. Eli Lilly And In Re Xencor (opens the original)
Read excerpt
In our companion article, Pharmaceutical Method-of-Use Claims After Teva v. Eli Lilly and In re Xencor: Written Description, Enablement, and the Known-Compound Genus, we analyzed two recent Federal Circuit decisions that offer complementary guidance on a recurring question in patent law: what must a patent specification disclose to satisfy written description and enablement under 35 U.S.C. § 112 when the claimed invention is the new use of a genus of known compounds or compositions? In Teva Phar
Pharmaceutical Method-Of-Use Claims After Teva v. Eli Lilly And In Re Xencor: Written Description, Enablement, And The Known-Compound Genus (opens the original)
Read excerpt
Two recent Federal Circuit decisions offer complementary guidance on a recurring question in patent law: what must a patent specification disclose to satisfy written description and enablement under 35 U.S.C. § 112 when the claimed invention is the new use of a genus of known compounds or compositions? Teva Pharm. Int’l GmbH v. Eli Lilly & Co., 172 F.4th 1367 (Fed. Cir. 2026), and In re Xencor, Inc., 130 F.4th 1350 (Fed. Cir. 2025), reach different outcomes on superficially similar facts. The co
AI Meets The Clinic At UC San Diego's New Health Intelligence Institute (opens the original)
Read excerpt
One of the genuine privileges of practicing as a patent attorney is witnessing technologies evolve from concept to real-world application, particularly when they address long-felt, unmet needs. The announcement this week from UC San Diego offers a compelling example of exactly that trajectory. UC San Diego recently announced the formal launch of its Institute for Applied Health Intelligence. The new institute is a multidisciplinary hub designed to leverage AI and digital technology to improve he
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 500K sites
For Mondaq, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.